Oberland Capital is a healthcare focused investment firm that provides non-dilutive capital to life sciences companies. The firm specializes in structured finance and royalty monetization, offering innovative financing solutions tailored to the unique needs of healthcare companies.

Oberland Capital is a private investment firm formed in 2013 with assets under management in excess of $3 billion, focused exclusively on investing in the global healthcare industry and specializing in flexible investment structures customized to meet the specific needs of its transaction partners. Oberland Capital’s broad suite of financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investments in traditional debt and equity. With a combination of deep industry knowledge and extensive structured finance experience, the Oberland Capital team has a history of creating value for its transaction partners.

Centessa Pharmaceuticals

Zealand Pharma

COM:OBERLANDCAPITAL

Oberland Capital

Analysis Not Available